Improvement of motor function in mice after implantation of mononuclear stem cells from human umbilical cord and placenta blood after 3 and 6 weeks of experimental spinal cord injury

• Published in: Clinics (São Paulo, Brazil) Vol. 79; p. 100509
• Main Authors: Araujo, Thiego Pedro Freitas, Cristante, Alexandre Fogaça, Marcon, Raphael Martus, Santos, Gustavo Bispo dos, Nicola, Maria Helena Alves, Araujo, Alex Oliveira de, Sanchez, Fernando Barbosa, Barros Filho, Tarcísio Eloy Pessoa de
• Format: Journal Article
• Language: English
• Published: United States Elsevier España, S.L.U 01-01-2024
• Subjects: Histopathological evaluation; Mesenchymal stem cells; Motor evaluation; Spinal cord trauma; Umbilical cord; Motor evaluation; Umbilical cord; Spinal cord trauma; Histopathological evaluation; Mesenchymal stem cells
• ISSN: 1807-5932; 1980-5322; 1980-5322
• DOI: 10.1016/j.clinsp.2024.100509

•The chronic stage of spinal cord injury is the less studied group in animal models.•The biggest pool of patients with spinal cord injury are in a chronic stage.•Human umbilical cord and placental blood are highly available and can be used allogeneically.•Mice showed improved motor function after implantation of stem cells in the chronic stage.•Better function was achieved when stem cells were implanted near the subacute phase (3 weeks > 6 weeks).
Experimental study utilizing with a standardized model (MASCIS Impactor) of Spinal Cord Injury (SCI) in Balb C mouse model with implantation of mononuclear stem cells derived from the human umbilical cord and placenta blood in the early chronic phase of SCI.
The aim of this study was to evaluate the nerve regeneration and motor functional recovery in Balb C mice with surgically induced paraplegia in response to the use of mononuclear stem cells, in early chronic phase (> 2 weeks and < 6 months), because there is yet potential of neuronal and functional recovery as the neuronal scar is not still completely established.
Forty-eight mice were randomly assigned to 6 groups of 8 animals. Group 1 received the stem cells 3 weeks after the trauma, and Group 2 received them six weeks later. In Group 3, saline solution was injected at the site of the lesion 3 weeks after the trauma, and in Group 4, 6 weeks later. Group 5 underwent only spinal cord injury and Group 6 underwent laminectomy only. The scales used for motor assessment were BMS and MFS for 12 weeks.
The intervention groups showed statistically significant motor improvement. In the histopathological analysis, the intervention groups had a lower degree of injury (p < 0.05). Regarding axonal budding, the intervention groups showed increasing in axonal budding in the caudal portion (p < 0.05).
The use of stem cells in mice in the chronic phase after 3 and 6 weeks of SCI brings functional and histopathological benefits to them.